| First Author | Kramer ED | Year | 2023 |
| Journal | JCI Insight | Volume | 8 |
| Issue | 8 | PubMed ID | 37092550 |
| Mgi Jnum | J:345945 | Mgi Id | MGI:7489043 |
| Doi | 10.1172/jci.insight.160978 | Citation | Kramer ED, et al. (2023) beta-Catenin signaling in alveolar macrophages enhances lung metastasis through a TNF-dependent mechanism. JCI Insight 8(8) |
| abstractText | The main cause of malignancy-related mortality is metastasis. Although metastatic progression is driven by diverse tumor-intrinsic mechanisms, there is a growing appreciation for the contribution of tumor-extrinsic elements of the tumor microenvironment, especially macrophages, which correlate with poor clinical outcomes. Macrophages consist of bone marrow-derived and tissue-resident populations. In contrast to bone marrow-derived macrophages, the transcriptional pathways that govern the pro-metastatic activities of tissue-resident macrophages (TRMs) remain less clear. Alveolar macrophages (AMs) are a TRM population with critical roles in tissue homeostasis and metastasis. Wnt/beta-catenin signaling is a hallmark of cancer and has been identified as a pathologic regulator of AMs in infection. We tested the hypothesis that beta-catenin expression in AMs enhances metastasis in solid tumor models. Using a genetic beta-catenin gain-of-function approach, we demonstrated that (a) enhanced beta-catenin in AMs heightened lung metastasis; (b) beta-catenin activity in AMs drove a dysregulated inflammatory program strongly associated with Tnf expression; and (c) localized TNF-alpha blockade abrogated this metastatic outcome. Last, beta-catenin gene CTNNB1 and TNF expression levels were positively correlated in AMs of patients with lung cancer. Overall, our findings revealed a Wnt/beta-catenin/TNF-alpha pro-metastatic axis in AMs with potential therapeutic implications against tumors refractory to the antineoplastic actions of TNF-alpha. |
